A Randomized Controlled Trial of the Emotion Awareness and Skills Enhancement (EASE) Program for ASD
Technical Report,01 Aug 2018,31 Jul 2019
University of Pittsburgh Pittsburgh United States
Pagination or Media Count:
The primary objective of this study is to formally evaluate efficacy of the Emotion Awareness and Skills Enhancement EASE via a sufficiently powered, two-site randomized controlled trial RCT. This is consistent with several FY17 ARP areas of interest, namely 1 EASE is a behavioral, non-pharmacological therapy that 2 alleviates co-occurring conditions EASE aims to decrease, depression, anxiety, and aggression by improving ER, and 3 promotes success during the transition to adulthood. The Specific Aims include Aim 1 Primary OutcomeShow that EASE improves ER Aim 2 Secondary Outcomes Demonstrate that EASE results in decreased functional impairment and reduced psychiatric symptoms and problem behaviors Aim 3 Durability Examine the trajectory of change including the degree to which effects are sustained after treatment completion Aim 4 Exploratory - Mediators Evaluate whether changes in ER and mindfulness mediate improvements. Hypotheses We hypothesized that EASE will improve ER, decrease psychiatric symptoms and problem behaviors, and reduce functional impairment, and that the effects will be sustained. Currently, we have completed Year 1 of this four-year project above our projected recruitment targets, with 67 of 200 participants recruited, 45 participants screened, 43 enrolled, and 23 who have already completed the study.
- Medicine and Medical Research